CELL & GENE COLLABORATIVE BLOG

From Manufacturing Floor To C-Suite: “Scaling Up” Cell & Gene Therapy Communication
Though "communicate often" is a commonly offered best practice in the CGT space, it’s rarely discussed what this can and should look like, especially when it comes to elevating information from the manufacturing floor/team up to the C-Suite. My conversation with Mark Gergen, CEO of Poseida Therapeutics, however, gives us a great look of what this can look like for growing CGT companies.
Continue Reading..

The “Renaissance” Approach To Cell & Gene Therapy Manufacturing
We’re all familiar with the concept of the “Renaissance Man/Woman". In the context of the CGT space, however, can there be such a thing as a “Renaissance Company”? My conversation with Poseida Therapeutics' CEO Mark Gergen proves that there can be and establishes why a generalist mindset is necessary to bring the CGT manufacturing paradigm to maturity.
Continue Reading..

ARW’s C&G (+RNA!) Manufacturing Must-Reads (Dracula Edition!)
Day-in and day-out, I write, read, listen to, and watch as much content as I can about C&G therapy manufacturing, in particular, and/or other C&G industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email. But inboxes can be shifty...
Continue Reading..

Can USP, NIST, & NIIMBL Conquer The Biggest AAV Quality Challenge?
As the CGT industry continues struggling to sufficiently characterize its AAV, USP's Fouad Atouf and I unpacked the ins-and-outs of this ongoing USP, NIST, and NIIMBL AAV quality initiative — as well as the CGT industry’s greatest needs from such a collaboration.
Continue Reading..

ARW’s C&G Manufacturing Must-Reads (The Simpsons Edition!)
Day-in and day-out, I write, read, listen to, and watch as much content as I can about C&G therapy manufacturing, in particular, and/or other C&G industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email. But inboxes can be shifty...
Continue Reading..

ARW’s Cell & Gene Manufacturing Must-Reads (Classic Literature Edition!)
Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format and send them out via email. For this April 21 edition, I decided to play with the “Thank You For Libraries Day” theme. Below, each section of articles includes a quote and several not-so-subtle references to classic works of literature you’d likely find in any of the...
Continue Reading..

Time Well-Spent: Embracing Opportunity Costs In Gene Therapy Manufacturing
It goes without saying that “taking time” to get a solid process in place is a best practice. But what I particularly appreciated about my conversation with Tenaya CTO's Kee-Hong Kim was how his own experiences and perspectives helped define what exactly “time well spent” means in the CGT development process.
Continue Reading..

ARW’s C&G Manufacturing Must-Reads (GIANT RODENT! Edition)
Day-in and day-out, I write, read, listen to, and watch as much content as I can about C&G therapy manufacturing, in particular, and/or other C&G industry-related topics that you should at least be aware of in the manufacturing facility. Every two weeks, I compile the articles and industry updates I think are most worthy of your time into an unconventional newsletter format (below) and send them out via email. But inboxes can be shifty...
Continue Reading..

Show Me The Money! A Closer Look At COGS In Gene Therapy Manufacturing
It’s almost inevitable that any conversation about manufacturing will be filled with references to “Time” and “Money,” and my conversation with Tenaya CTO, Kee-Hong Kim was no exception. But while these words can be dangerously vague, Kim’s experience added some valuable context into how he approaches these two resources in his role — starting first with “money.”
Continue Reading..

Your C&G Manufacturing Must-Reads (Philly Cheesesteak Edition!)
Here’s a “permanent” copy of my C&G Manufacturing Must-Reads newsletter that was delivered on March 24, which just happened to be National Cheesesteak Day. Ergo, this is the “Philly Cheesesteak edition” of your manufacturing must-reads, in honor of our many friends in “Cellicon Valley”/Philadelphia.
Continue Reading..
This website uses cookies to ensure you get the best experience on our website. Learn more